Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RSV virus
CRO
CRO hVIVO inks deal to test RSV drug in human challenge trial
CRO hVIVO inked a $8.2 million deal to run a human challenge test for an undisclosed company's respiratory syncytial virus antiviral drug candidate.
Joseph Keenan
Feb 8, 2023 10:10am
Moderna sprints toward RSV podium behind GSK, Pfizer
Jan 4, 2023 3:37pm
Ex-GSK vaccine R&D chief to lead new vax venture, launch RSV jab
Jul 21, 2022 11:05am
Moderna's RSV shot sails on to phase 3 after safety review
Feb 22, 2022 10:20am
Moderna readies deeper line up of mRNA vaccine candidates
Apr 14, 2021 7:00am
Biotech builder ElevateBio reveals its first portfolio company: AlloVir
May 22, 2019 7:00am
